These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38977962)

  • 1. Prognostic and clinicopathological significance of tertiary lymphoid structure in non-small cell lung cancer: a systematic review and meta-analysis.
    Ma L; Li R; Liu X; Yu W; Tang Z; Shen Y; Tian H
    BMC Cancer; 2024 Jul; 24(1):815. PubMed ID: 38977962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer.
    Xin S; Wen S; He P; Zhao Y; Zhao H
    Front Immunol; 2024; 15():1423775. PubMed ID: 39192984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors.
    Zhao Z; Ding H; Lin ZB; Qiu SH; Zhang YR; Guo YG; Chu XD; Sam LI; Pan JH; Pan YL
    Int J Med Sci; 2021; 18(11):2327-2338. PubMed ID: 33967609
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.
    Berthe J; Poudel P; Segerer FJ; Jennings EC; Ng F; Surace M; Andoni A; Testori M; Saraiya M; Vuko M; Hessel H; Heininen-Brown M; Blando J; Jones EV; Willis SE; Galon J; van de Ven R; de Gruijl TD; Angell HK
    Front Immunol; 2024; 15():1422206. PubMed ID: 39376565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer.
    Xiaoxu D; Min X; Chengcheng C
    BMC Pulm Med; 2024 Mar; 24(1):155. PubMed ID: 38532454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
    Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
    Front Immunol; 2022; 13():868155. PubMed ID: 35664009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer.
    Rakaee M; Kilvaer TK; Jamaly S; Berg T; Paulsen EE; Berglund M; Richardsen E; Andersen S; Al-Saad S; Poehl M; Pezzella F; Kwiatkowski DJ; Bremnes RM; Busund LR; Donnem T
    Br J Cancer; 2021 May; 124(10):1680-1689. PubMed ID: 33723388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
    Xu F; Zhu H; Dong Y; Li L; Liu N; Yuan S
    Front Immunol; 2023; 14():1244256. PubMed ID: 38155965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
    Li D; Cao Y; Luo CW; Zhang LP; Zou YB
    Recent Pat Anticancer Drug Discov; 2024; 19(5):599-609. PubMed ID: 37818578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
    Min SH; Zheng QQ
    Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis.
    Yan Q; Li S; He L; Chen N
    Front Immunol; 2024; 15():1476365. PubMed ID: 39372398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of tertiary lymphoid structures in hepatocellular carcinoma: a meta-analysis and systematic review.
    Hu L; Li X; Yang C; Zhou B; Du C; Jiang N
    Front Immunol; 2024; 15():1390938. PubMed ID: 38887293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma.
    Siliņa K; Soltermann A; Attar FM; Casanova R; Uckeley ZM; Thut H; Wandres M; Isajevs S; Cheng P; Curioni-Fontecedro A; Foukas P; Levesque MP; Moch H; Linē A; van den Broek M
    Cancer Res; 2018 Mar; 78(5):1308-1320. PubMed ID: 29279354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer.
    Weng Y; Yuan J; Cui X; Wang J; Chen H; Xu L; Chen X; Peng M; Song Q
    Sci Rep; 2024 Jul; 14(1):16246. PubMed ID: 39009684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the tertiary lymphoid structure in gastrointestinal cancers.
    Yu A; Cao M; Zhang K; Yang Y; Ma L; Zhang X; Zhao Y; Ma X; Fan Z; Han Z; Wang H
    Front Immunol; 2023; 14():1256355. PubMed ID: 37868990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study.
    Fukuhara M; Muto S; Inomata S; Yamaguchi H; Mine H; Takagi H; Ozaki Y; Watanabe M; Inoue T; Yamaura T; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Shio Y; Suzuki H
    Cancer Immunol Immunother; 2022 May; 71(5):1129-1137. PubMed ID: 34596720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma.
    Wu S; Pan J; Pan Q; Zeng L; Liang R; Li Y
    Front Immunol; 2024; 15():1453220. PubMed ID: 39364403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.
    Tamiya Y; Nakai T; Suzuki A; Mimaki S; Tsuchihara K; Sato K; Yoh K; Matsumoto S; Zenke Y; Nosaki K; Izumi H; Shibata Y; Sakai T; Taki T; Miyazaki S; Watanabe R; Sakamoto N; Sakashita S; Kojima M; Hashimoto N; Tsuboi M; Goto K; Ishii G
    Lung Cancer; 2022 Dec; 174():125-132. PubMed ID: 36379125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.